Skip to main content
logo
High Tech Pharm Co., Ltd. (KOSDAQ:106190)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,310
+10 (0.10%)
At close: Sep 11, 2026

High Tech Pharm Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
69,40970,18377,51376,772102,94773,287
Revenue Growth
-7.03%-9.46%0.97%-25.43%40.47%-1.58%
Gross Profit
18,97516,93719,48112,8347,7703,071
Operating Income
12,27312,85615,55810,0894,927-412.02
Net Income
11,92711,47513,7108,0765,873-1,225
Earnings Per Share
-1072.371289.431139.33552.32-115.24
EPS Growth
--16.83%13.17%106.28%--

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3,00014,4307,7595,3657,88012,637
Total Debt
20.5733.618,00216,50016,42415,978
Net Cash (Debt)
2,97914,396-243.03-11,135-8,543-3,340
Net Cash Growth
-57.11%-----
Net Cash Per Share
-1345.34-22.86-1570.78-803.46-314.15

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-904.717,02814,6912,909-3,7036,928
Capital Expenditures
-1,409-1,926-2,133-5,091-655.97-859.6
Free Cash Flow
-2,31415,10212,558-2,183-4,3596,068
Free Cash Flow Growth
-20.25%----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
27.34%24.13%25.13%16.72%7.55%4.19%
Operating Margin
17.68%18.32%20.07%13.14%4.79%-0.56%
Pretax Margin
20.90%19.70%22.04%12.85%3.91%-1.18%
Profit Margin
17.18%16.35%17.69%10.52%5.71%-1.67%
FCF Margin
-3.33%21.52%16.20%-2.84%-4.23%8.28%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
9.1911.1410.8612.2813.16-
P/FCF Ratio
-8.4611.85--16.00
PS Ratio
1.581.821.921.290.751.33